Leerink Partners is serving as exclusive financial advisor to Tectonic and Cooley LLP is serving as legal counsel to Tectonic. Leerink Partners and TD Cowen are...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell and Conyers Dill & Pearman advised Roivant Sciences Ltd. on the offering. Cooley advised Immunovant on the transaction. Roivant Sciences Ltd. (Nasdaq:ROIV)...
You must be a Standard 1 Year member to access this content.
Cooley represented Immunovant, while Latham & Watkins represented the underwriters in the offering. Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company committed to enabling normal lives for...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Exscientia on the deal while Goodwin Procter represented Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, BofA Securities and Barclays Capital...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Goldman Sachs & Co. LLC and the other underwriters on the deal. Hogan Lovells and Cooley advised Valneva. Gide advised Goldman Sachs, Jefferies,...
You must be a Standard 1 Year member to access this content.
Cooley LLP advised Exscientia on the deal. Exscientia, a clinical-stage pharmatech company, announced its $225 million Series D funding round led by SoftBank Vision Fund 2, which...
You must be a Standard 1 Year member to access this content.
